Depending on the existence and/or absence of various hormone receptors, such as estrogen receptor (ER), progesterone receptor (PR) and the receptor for the human epidermal growth factor (HER2), the disease can be classified in subtypes, the most aggressive one being triple-negative breast cancer (TNBC) [147]. Here, PGR is linked to triple-negative breast carcinoma.